Detalles de la búsqueda
1.
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.
Circulation
; 122(6): 614-22, 2010 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20660806
2.
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation
; 118(16): 1626-36, 2008 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-18757948
Resultados
1 -
2
de 2
1
Próxima >
>>